Indian drugmakers say meds billed as substandard are fake

Two medicines that failed product quality testing by India’s drug regulatory agency were counterfeit, say the manufacturers of the brands.

Batches of GlaxoSmithKline’s topical steroids Betnovate-N and Betnovate-C and Macleods’ Panderm ++ antimicrobial cream, along with other products, were deemed to be substandard by India’s Central Drugs Standard Control Organisation (CDSCO) earlier this month, reports

GSK said two batches of Betnovate-N and Betnovate-C included in the quality alert (PDF) were “counterfeit batches which were seized by Delhi Drug Control.” Macleods meanwhile said the batch number listed for Panderm ++ in the report was not legitimate.

Related articles:

     Want our news sent directly to your inbox?

Yes please 2


Home  |  About us  |  Contact us  |  Advertise  |  Links  |  Partners  |  Privacy Policy  |   |  RSS feed   |  back to top